September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
Big data for better results: the power and the promise of precision medicine
September 26, 2018 | Sam Lazaryev
Jeff Trent, Ph.D., TGen president and research director, discusses the promise of precision medicine and his company’s exciting initiative with City of Hope.
TGen Tackles Diabetic Blindness with New Collaboration
September 25, 2018 | City of Hope
City of Hope affiliate TGen has been awarded a $2.8 million grant in an effort to discover new treatments for diabetic retinopathy.
Researcher's Ovarian Cancer Discovery Takes on Special Meaning
June 27, 2018 | City of Hope
The results of a study published earlier this year by TGen researchers (City of Hope affiliate) in the journal Clinical Cancer Research suggest an existing leukemia drug, ponatinib, shows promise against SCCOHT.
Sound Therapy: TGen Tests Ultrasound to Enhance Cancer Drug Delivery
March 26, 2018 | City of Hope
City of Hope affiliate TGen has teamed up with a Norwegian biotech company to test the use of ultrasounds to direct and focus cancer drug therapies.
Leukemia Drug Shows Promise Against Rare Ovarian Cancer
March 2, 2018 | City of Hope
City of Hope affiliate TGen has found that an anti-cancer drug used to fight leukemia shows promise against SCCOHT, a rare and aggressive type of ovarian cancer.
'Marley Team' seeks to develop early pancreatic cancer screening tools
January 9, 2018 | Stephanie Smith
A multi-institutional partnership, funded in part by a multimillion-dollar grant from the Kemper and Ethyl Marley Foundation, is designed to develop a “mammogram” for pancreatic cancer.
TGen Spotlight: New Study Tackles Sports-Related Concussions
October 16, 2017 | City of Hope
TGen-Riddell partnership results could help future studies lead to advanced methods of injury and disease detection
New Compound Discovered in the Battle Against Brain Cancer
January 30, 2017 | City of Hope
A study led by scientists at the Translational Genomics Research Institute (TGen), a City of Hope affiliate, has identified "a potent inhibitory compound" in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer.
City of Hope's Steven T. Rosen, M.D., on the Impact of the TGen Alliance
December 1, 2016 | City of Hope
In this Q and A, Steven T. Rosen, M.D., provost and chief scientific officer for City of Hope, answers questions about the importance of precision of medicine in the fight against cancer and how the City of Hope and TGen alliance will advance research and treatment using this approach.